Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 known ✓ | P21453 | 2/20 | 0.41 |
| ▸ | PPARG known ✓ | P37231 | 1/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.42 |
| ▸ | CYSLTR2 | Q9NS75 | 4/20 | 0.41 |
| ▸ | CYSLTR1 | Q9Y271 | 4/20 | 0.41 |
| ▸ | BID | P55957 | 3/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.40 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.40 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.40 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.40 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.40 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.40 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6365533 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL108306 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL127365 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL7630157 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL29244 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL7632464 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL7636984 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL7637101 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL7633346 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 | |
| Hydrochloric Acid SCHEMBL526177 | 1.00 | LIPG (0.50) | LIPGNR1H2NR1H3CYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1579 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4701612-A1 | HAIR TREATMENT COMPOSITIONS | Unilever IP Holdings B.V. (NL) | 2026-03-04 | — | — | EP | claimed |
| US-12458574-B2 | Deposition system for hair | CONOPCO, INC. (US) | 2025-11-04 | — | — | US | claimed |
| US-12447118-B2 | Hair treatment compositions | CONOPCO, INC. (US) | 2025-10-21 | — | — | US | claimed |
| US-12280131-B2 | Deposition system for hair | CONOPCO, INC. (US) | 2025-04-22 | — | — | US | claimed |
| WO-2025073624-A1 | HAIR STRAIGHTENING COMPOSITIONS AND METHODS OF USING THEREOF | UNILEVER IP HOLDINGS B.V. (NL) | 2025-04-10 | — | — | WO | claimed |
| WO-2024223432-A1 | HAIR TREATMENT COMPOSITIONS | UNILEVER IP HOLDINGS B.V. (NL) | 2024-10-31 | — | — | WO | claimed |
| US-12076432-B2 | Method of repairing oxidatively treated hair | CONOPCO, INC. (US) | 2024-09-03 | — | — | US | claimed |
| US-9889079-B2 | Process for making a conditioning gel phase | CONOPCO, INC. (US) | 2018-02-13 | — | — | US | claimed |
| US-9295859-B2 | Porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-29 | — | — | US | claimed |
| WO-2013131756-A2 | HAIR CARE COMPOSITION | UNILEVER PLC (GB) | 2013-09-12 | — | — | WO | claimed |
| EP-1434554-B1 | HAIR TREATMENT COMPOSITIONS WHICH PROVIDE HAIR BODY AND WHICH COMPRISE SILICONE PRESSURE SENSITIVE ADHESIVES | UNILEVER PLC (GB) | 2011-05-11 | — | — | EP | claimed |
| US-6787130-B2 | AQUEOUS SOLUTIONS CONTAINING HAIR CONDITIONER, CLEANING COMPOUND AND SUSPENSION AGENT; RINSABLE | UNILEVER HOME & PERSONAL CARE USA A DIVISION OF CONOPCO, INC. | 2004-09-07 | — | — | US | claimed |
| EP-1434554-A1 | HAIR TREATMENT COMPOSITIONS WHICH PROVIDE HAIR BODY AND WHICH COMPRISE SILICONE PRESSURE SENSITIVE ADHESIVES | UNILEVER PLC (GB) | 2004-07-07 | — | — | EP | claimed |
| US-20030091523-A1 | Hair treatment compositions which provide hair body and which comprise silicone pressure sensitive adhesives | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-05-15 | — | — | US | claimed |
| WO-2003028677-A1 | HAIR TREATMENT COMPOSITIONS WHICH PROVIDE HAIR BODY AND WHICH COMPRISE SILICONE PRESSURE SENSITIVE ADHESIVES | UNILEVER PLC (GB) | 2003-04-10 | — | — | WO | claimed |
| US-20020170237-A1 | Polishing slurry for the chemical-mechanical polishing of silica films | BAYER AKTIENGESELLSCHAFT (DE) | 2002-11-21 | — | — | US | claimed |
| US-6482791-B2 | .1-7% OF HYPCHLOROUS ACID ALKALI SALT, .01-3% OF A QUATERNARY AMMONIUM SALT, .1-3% OF AT LEAST ONE OF CUMENESULFONIC ACID, XYLENESULFONIC ACID, TOLUENESULFONIC ACID AND SALTS THEREOF, .2-3% OF AN ALKALI HYDROXIDE AND WATER | KAO CORPORATION (JP) | 2002-11-19 | — | — | US | claimed |
| US-20020151455-A1 | Liquid bleach cleaner composition | KAO CORPORATION (JP) | 2002-10-17 | — | — | US | claimed |
| WO-2001085112-A2 | SHAVING CREAM FORMULATIONS | AUSTRALIAN IMPORTERS, LTD. (US) | 2001-11-15 | — | — | WO | claimed |
| US-5344738-A | Process of making toner compositions | XEROX CORPORATION (US) | 1994-09-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12280131-B2 | Deposition system for hair | PRDX5, DECR2, PLIN3 | S1PR1 177/4885PPARG 25/4885LIPG 3987/4885 |
| US-12447118-B2 | Hair treatment compositions | SLC25A1, OAT, OTC | S1PR1 1486/4885PPARG 2347/4885LIPG 4433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.